Screener
Prime Medicine PRME Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Prime Medicine’s reported figures.
Based on the most recent quarter.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's debt-to-equity?
- Prime Medicine (PRME) reported debt-to-equity of 2.8× in Q2 2026.
- How has Prime Medicine's debt-to-equity changed year-over-year?
- Prime Medicine's debt-to-equity increased by 43.6% year-over-year, from 2× to 2.8×.
- What is the long-term trend for Prime Medicine's debt-to-equity?
- Over 4 years (2020 to 2025), Prime Medicine's debt-to-equity has grown at a -4.4% compound annual growth rate (CAGR), from 1.2× to 1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Prime Medicine's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude